Growth inhibitory peptides: a potential novel therapeutic approach to cancer treatment
Authors:
- 27 March 2025
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 996, 177554
Abstract
No abstract availableKeywords
Funding Information
- Beijing Natural Science Foundation (7222157)
- National Natural Science Foundation of China (82003809)
This publication has 112 references indexed in Scilit:
- Mucosomes: Intrinsically Mucoadhesive Glycosylated Mucin Nanoparticles as Multi‐Drug Delivery PlatformAdvanced Healthcare Materials, 2022
- Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2021
- Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in ChinaCancer Medicine, 2020
- Therapeutic use of human alpha‐fetoprotein in clinical patients: Is a cancer risk involved?International Journal of Cancer, 2010
- Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancerCancer Immunology, Immunotherapy, 2007
- A METASTATIC BREAST TUMOR CELL LINE, GI‐101A, IS ESTROGEN RECEPTOR POSITIVE AND RESPONSIVE TO ESTROGEN BUT RESISTANT TO TAMOXIFENCell Biology International, 1998
- Stimulation of tumor-cell growth by alpha-fetoproteinInternational Journal of Cancer, 1998
- ALPHA‐FETOPROTEIN‐MEDIATED TARGETING—A NEW STRATEGY TO OVERCOME MULTIDRUG RESISTANCE OF TUMOUR CELLS IN VITROCell Biology International, 1997
- In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrixBritish Journal of Surgery, 1995
- Hypothesis: An apparent dimerization motif in the third domain of alphafetoprotein: Molecular mimicry of the steroid/thyroid nuclear receptor superfamilyBioEssays, 1993